The Global Human Microbiome Therapeutics Market is expected to grow by $ 516.08 mn during 2021-2025, progressing at a CAGR of 47.79% during the forecast period

by NASDAQ Market News November 23, 2021

NASDAQ Market News
Click here to email author

Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

The Global Disposable Hospital Supplies Market is expected to grow by $ 43.41 bn during 2021-2025, decelerating at a CAGR of 8.20% during the forecast period

Ads